Alle Studien
Aktiv, aber nicht rekrutierendNAINTERVENTIONELL

Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related Macular Degeneration

This study is investigating a new, tiny telescope implant called SING IMT 3X for people in the UK who have severe, ‘end-stage’ age-related macular degeneration (AMD). AMD causes central blurry vision, making it hard to see faces or read. The aim is to check if this implant is safe and if it can help improve vision for those affected. Patients who are suitable will have the implant placed during a routine cataract operation. After surgery, they will attend regular eye check-ups and vision training sessions for 12 months to help them learn how to use their improved vision. This study will help doctors understand how well the implant works in real-world settings.

Auf einen Blick

Status
Aktiv, aber nicht rekrutierend
Phase
NA
Sponsor
VisionCare, Inc.
Einschreibeziel
68
Starten
13 Sep 2022
Geschätzte Fertigstellung
01 Dec 2028

Worum geht es in dieser Studie?

This study is looking into a new type of treatment for people living with severe age-related macular degeneration, often called AMD. AMD is a common eye condition that affects the central part of your vision, making it difficult to do everyday tasks like reading, recognising faces, or driving. This study focuses on people with 'end-stage' AMD, meaning their vision loss is quite advanced.

The treatment being studied is a tiny device called the SING IMT 3X. Think of it like a miniature telescope that is implanted inside the eye. The idea behind it is to magnify images onto a healthier part of the retina (the light-sensitive layer at the back of your eye) so that your central vision can be improved. This study aims to find out if this implant is both safe to use and effective at helping to improve vision for people with severe AMD.

This is a 'post-market' study, which means the device may already be available in some places, but researchers are gathering more information about its performance and safety in a broader group of people. If you qualify and choose to take part, you would have the tiny telescope placed during a routine cataract operation. Following the surgery, you’d receive ongoing support, including regular eye appointments and special vision training to help you get the most out of the implant and adjust to your improved vision.

Wichtige Erkenntnisse

  • This study is for people with severe age-related macular degeneration (AMD).
  • It tests a tiny telescope implant (SING IMT) to improve central vision.
  • Participation involves surgery and about 12 months of follow-up care and vision training.
  • You must meet specific vision and health criteria to be eligible.
  • The aim is to understand if the implant is safe and effective in real-world use.

Wer könnte berechtigt sein?

To be considered for this study, you would generally need to be 55 years old or older and have certain signs of advanced AMD in your eyes, such as specific changes detected by eye scans. You would also need to have cataracts, which is a common clouding of the eye's natural lens. Your vision in both eyes would typically be quite poor, generally not better than 20/80 and not worse than 20/800.

Critically, before the actual implant, you'd undergo a special vision test using a trial magnifying device. To go forward with the surgery, this test must show that your vision in the eye to be treated would improve by a certain amount (at least 5 letters on an eye chart). You also need to have good enough side vision in your other eye.

There are also reasons why you might not be able to join. For example, if you've had recent treatment for another serious AMD-related condition, have certain other eye problems like uncontrolled glaucoma, or have had other eye surgeries in the eye to be treated, you wouldn't be eligible. It's also important that you're willing to commit to the follow-up appointments and vision training.

Könnte diese Studie für Sie geeignet sein?

Beantworten Sie diese kurzen Fragen, um zu sehen, ob Sie möglicherweise berechtigt sind. Dies ist nur ein Leitfaden – das Forschungsteam trifft die endgültige Entscheidung.

  1. Are you 55 years old or older?
  2. Do you have severe AMD and cataracts?
  3. Is your central vision quite poor in both eyes?
  4. Would your central vision improve when tested with a special magnifying lens?
  5. Are you able to commit to follow-up eye appointments and vision training for about a year?
  6. Do you not have other serious eye conditions, like uncontrolled glaucoma?
Beantworten Sie jede Frage, um Ihr Ergebnis zu sehen.

Was beinhaltet die Teilnahme?

If you decide to take part and meet all the eligibility criteria, you would first sign a consent form. You'd then have an out-patient surgery to implant the SING IMT device, which would be done at the same time as a routine cataract operation. After the surgery, you'll have regular eye check-ups, typically over a period of 12 months, to monitor your eye health and the implant's effectiveness.

Crucially, you would also attend 6 to 10 additional visits with a low vision specialist. These are dedicated training sessions to help you learn how to use your vision with the new implant effectively. The study team will carefully monitor any potential complications, known as 'adverse events', and track any medications you are taking throughout the study period. The total duration of your active participation, including all follow-up appointments, is about 12 months.

Potenzielle Risiken und Vorteile

Taking part in this study could potentially offer a significant benefit by improving your central vision, which might make everyday tasks easier. However, like any surgical procedure, there are potential risks, such as infection, bleeding, or issues with the implant itself. The study will carefully monitor for any complications. You are always free to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Standorte (13)

  • UZ Brussel
    Verifizierte Postleitzahl
    Brüssel, Belgien
  • Centre d'Ophtalmologie Paradis-Monticelli
    Verifizierte Postleitzahl
    Marseille, Frankreich
  • Hélios Ophtalmologie, Saint-Jean-de-Luz
    Verifizierte Postleitzahl
    Saint-Jean-de-Luz, France
  • CHRU de Strasbourg
    Verifizierte Postleitzahl
    Straßburg, Frankreich
  • Augenklinik Städtisches Klinikum Karlsruhe
    Verifizierte Postleitzahl
    Karlsruhe, Germany
  • Universitätsklinikum Münster Klinik für Augenheilkunde
    Verifizierte Postleitzahl
    Münster, Germany
  • Mater Misericordiae University Hospital
    Verifizierte Postleitzahl
    Dublin, Ireland
  • Università degli Studi di Napoli Federico II
    Verifizierte Postleitzahl
    Neapel, Italien
  • Fondazione Policlinico Universitario Agostino Gemelli
    Verifizierte Postleitzahl
    Rom, Italien
  • VISSUM
    Verifizierte Postleitzahl
    Alicante, Spain
  • Institut OMIQ
    Verifizierte Postleitzahl
    Barcelona, Spanien
  • Hospital Universitario La Luz - Quirónsalud
    Verifizierte Postleitzahl
    Madrid, Spanien

Häufige Fragen

What is Age-related Macular Degeneration (AMD)?

AMD is a common eye condition that causes blurry vision or a blind spot in the centre of your sight, making it hard to see fine details.

What is the SING IMT 3X implant?

It's a tiny telescope that is surgically placed inside the eye to magnify what you see and help improve central vision for people with severe AMD.

Werde ich operiert, wenn ich an dieser Studie teilnehme?

Yes, if eligible, you would undergo an out-patient surgery to implant the device, typically combined with cataract removal.

Wie lange werde ich an der Studie beteiligt sein?

Your participation, including follow-up appointments and vision training, will last for about 12 months in total.

What is vision rehabilitation?

This is a type of training where specialists help you learn how to use your vision more effectively, especially after an implant like the one being studied.

Wie Sie mehr erfahren können

Sprechen Sie immer mit Ihrem Hausarzt oder Spezialisten, bevor Sie sich entscheiden, an einer Studie teilzunehmen.

Diskussion

Community-Diskussion

Bereitgestellt von unserem Forum bei community.patient.info. Bitte seien Sie respektvoll — dies ist kein medizinischer Rat.